Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing

Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing

Critical to facilitating SARS-CoV-2 point-of-care (POC) testing is assurance that viruses present in specimens are inactivated onsite prior to processing. Here, we conducted experiments to determine the virucidal activity of commercially available Viral Transport Mediums (VTMs) to inactivate SARS-Co...

Full description

Bibliographic Details
Main Authors: David van Bockel, C. Mee Ling Munier, Stuart Turville, Steven G. Badman, Gregory Walker, Alberto Ospina Stella, Anupriya Aggarwal, Malinna Yeang, Anna Condylios, Anthony D. Kelleher, Tanya L. Applegate, Andrew Vallely, David Whiley, William Rawlinson, Phillip Cunningham, John Kaldor, Rebecca Guy
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Viruses
Subjects:
SARS-CoV-2
inactivation
virucidal
diagnostic
Online Access:https://www.mdpi.com/1999-4915/12/11/1208

Internet

https://www.mdpi.com/1999-4915/12/11/1208

Similar Items